Genmab | 当期純利益

2022Q32023Q32024Q3

	Net Income	変化する		日付
Agios Pharmaceuticals	USD -96523000		1.04B	2024-12
Almirall	EUR 7.99M		590K	2024-06
Amarin	USD -25134000		26.66M	2024-09
Amgen	USD 627M		2.2B	2024-12
argenx SE	USD 774.16M		682.75M	2024-12
AstraZeneca	USD 1.5B		71M	2024-12
Bayer	EUR -335000000		3.85B	2024-12
BioMarin Pharmaceutical	USD 124.94M		18.86M	2024-12
Demant	DKK 1.19B		588.5M	2024-12
Exelixis	USD 139.86M		21.89M	2025-01
Fresenius Medical Care	EUR 66.9M		146.1M	2024-12
Galapagos	EUR 25.31M		75.74M	2024-12
Genmab	DKK 3.84B		2.58B	2024-12
GlaxoSmithKline	GBP 414M		472M	2024-12
GN Store Nord	DKK 367M		96M	2024-12
GRIFOLS	EUR 68.97M		17.28M	2024-12
Hikma Pharmaceutical	USD 226M		167M	2024-06
Insmed	USD -235548000		15.02M	2024-12
Lonza	CHF 329M		85M	2024-06
Merck	EUR 809M		202M	2024-09
Novartis	USD 2.82B		371M	2024-12
Regeneron Pharmaceuticals	USD 917.7M		422.9M	2024-12
Roche Holding	CHF 1.01B		2.12B	2024-12
Sanofi	EUR 2.82B		1.7B	2024-09
UCB	EUR 104M		72M	2024-06

Genmab 当期純利益 - 現在の値は、過去のデータ、予測、統計、チャートや経済カレンダー - Mar 2025.